Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer
International Journal of Cancer, 06/25/09
Nicholson LJ et al. - The data establish epigenetic inactivation of ASS1 as a determinant of response to platinum chemotherapy and imply that transcriptional silencing of ASS1 contributes to treatment failure and clinical relapse in ovarian cancer. The collateral sensitivity of cells lacking endogenous ASS1 to arginine depletion suggests novel therapeutic strategies for the management of relapsed ovarian cancer.
Related Articles
Increased endostatin generation and decreased angiogenesis via MMP-9 by tamoxifen in hormone dependent ovarian cancer
Cancer Letters, 12/04/09
Relevance Score: 70%%
Collagen and calcium-binding EGF domains 1 is frequently inactivated in ovarian cancer by aberrant promoter hypermethylation and modulates cell migration and survival
British Journal of Cancer, 11/30/09
Relevance Score: 70%%
Activity of the multikinase inhibitor dasatinib against ovarian cancer cells
British Journal of Cancer, 11/02/09
Relevance Score: 70%%
Breast-feeding the last born child and risk of ovarian cancer
Cancer Causes and Control, 11/16/09
Relevance Score: 69%%
Serous papillary peritoneal carcinoma: Unknown primary tumour, ovarian cancer counterpart or a distinct entity? A systematic review
Critical Reviews in Oncology/Hematology, 11/12/09
Relevance Score: 69%%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Co-expression of plexin-B1 and Met in human breast and ovary tumours enhances the risk of progression
Cellular Oncology, 12/07/09
Prognostic relevance of promoter hypermethylation of multiple genes in breast cancer patients
Cellular Oncology, 12/07/09
Differential apoptotic response of human cancer cells to organoselenium compounds
Cancer Chemotherapy and Pharmacology, 12/07/09
Today in Gynecologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Co-expression of plexin-B1 and Met in human breast and ovary tumours enhances the risk of progression
Cellular Oncology, 12/07/09
Oestrogen receptor 1 mRNA is a prognostic factor in ovarian cancer patients treated with neo-adjuvant chemotherapy: determination by array and kinetic PCR in fresh tissue biopsies
Endocrine-Related Cancer, 12/07/09
Estrogen receptor 1 mRNA is a prognostic factor in ovarian carcinoma: determination by kinetic PCR in formalin-fixed paraffin-embedded tissue
Endocrine-Related Cancer, 12/07/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


